INS and type 1 diabetes mellitus: Taken together, while advancements in insulin delivery technologies have improved glycemic management in T1D, protein’s complex and delayed metabolic effects continue to pose challenges across all insulin delivery modalities (MDI, standard pumps, and AID systems).